Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy
Abstract There are limited data on the effects of anthracyclines on right ventricular (RV) structure, function, and tissue characteristics. The goal of this study was to investigate the effects of anthracyclines on the RV using cardiac magnetic resonance (CMR). This was a post-hoc analysis of a pros...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86f331c601744a65ba8265c0d625b14e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:86f331c601744a65ba8265c0d625b14e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:86f331c601744a65ba8265c0d625b14e2021-12-02T16:35:05ZCardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy10.1038/s41598-021-96630-y2045-2322https://doaj.org/article/86f331c601744a65ba8265c0d625b14e2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96630-yhttps://doaj.org/toc/2045-2322Abstract There are limited data on the effects of anthracyclines on right ventricular (RV) structure, function, and tissue characteristics. The goal of this study was to investigate the effects of anthracyclines on the RV using cardiac magnetic resonance (CMR). This was a post-hoc analysis of a prospective study of 27 breast cancer (BC) patients (51.8 ± 8.9 years) using CMR prior, and up to 3-times after anthracyclines (240 mg/m2) to measure RV volumes and mass, RV extracellular volume (ECV) and cardiomyocyte mass (CM). Before anthracyclines, LVEF (69.4 ± 3.6%) and RVEF (55.6 ± 9%) were normal. The median follow-up after anthracyclines was 399 days (IQR 310–517). The RVEF reached its nadir (46.3 ± 6.8%) after 9-months (P < 0.001). RV mass-index and RV CM decreased to 13 ± 2.8 g/m2 and 8.13 ± 2 g/m2, respectively, at 16-months after anthracyclines. The RV ECV expanded from 0.26 ± 0.07 by 0.14 (53%) to 0.40 ± 0.1 (P < 0.001). The RV ECV expansion correlated with a decrease in RV mass-index (r = −0.46; P < 0.001) and the increase in CK-MB. An RV ESV index at baseline above its median predicted an increased risk of LV dysfunction post-anthracyclines. In BC patients treated with anthracyclines, RV atrophy, systolic dysfunction, and a parallel increase of diffuse interstitial fibrosis indicate a cardiotoxic response on a similar scale as previously seen in the systemic left ventricle.Thiago Ferreira de SouzaThiago Quinaglia SilvaLígia Antunes-CorreaZsofia D. DrobniFelipe Osório CostaSergio San Juan DertkigilWilson NadruzFabrício BrenelliAndrei C. SpositoJosé Roberto Matos-SouzaOtávio Rizzi CoelhoTomas G. NeilanMichael Jerosch-HeroldOtávio Rizzi Coelho-FilhoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Thiago Ferreira de Souza Thiago Quinaglia Silva Lígia Antunes-Correa Zsofia D. Drobni Felipe Osório Costa Sergio San Juan Dertkigil Wilson Nadruz Fabrício Brenelli Andrei C. Sposito José Roberto Matos-Souza Otávio Rizzi Coelho Tomas G. Neilan Michael Jerosch-Herold Otávio Rizzi Coelho-Filho Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
description |
Abstract There are limited data on the effects of anthracyclines on right ventricular (RV) structure, function, and tissue characteristics. The goal of this study was to investigate the effects of anthracyclines on the RV using cardiac magnetic resonance (CMR). This was a post-hoc analysis of a prospective study of 27 breast cancer (BC) patients (51.8 ± 8.9 years) using CMR prior, and up to 3-times after anthracyclines (240 mg/m2) to measure RV volumes and mass, RV extracellular volume (ECV) and cardiomyocyte mass (CM). Before anthracyclines, LVEF (69.4 ± 3.6%) and RVEF (55.6 ± 9%) were normal. The median follow-up after anthracyclines was 399 days (IQR 310–517). The RVEF reached its nadir (46.3 ± 6.8%) after 9-months (P < 0.001). RV mass-index and RV CM decreased to 13 ± 2.8 g/m2 and 8.13 ± 2 g/m2, respectively, at 16-months after anthracyclines. The RV ECV expanded from 0.26 ± 0.07 by 0.14 (53%) to 0.40 ± 0.1 (P < 0.001). The RV ECV expansion correlated with a decrease in RV mass-index (r = −0.46; P < 0.001) and the increase in CK-MB. An RV ESV index at baseline above its median predicted an increased risk of LV dysfunction post-anthracyclines. In BC patients treated with anthracyclines, RV atrophy, systolic dysfunction, and a parallel increase of diffuse interstitial fibrosis indicate a cardiotoxic response on a similar scale as previously seen in the systemic left ventricle. |
format |
article |
author |
Thiago Ferreira de Souza Thiago Quinaglia Silva Lígia Antunes-Correa Zsofia D. Drobni Felipe Osório Costa Sergio San Juan Dertkigil Wilson Nadruz Fabrício Brenelli Andrei C. Sposito José Roberto Matos-Souza Otávio Rizzi Coelho Tomas G. Neilan Michael Jerosch-Herold Otávio Rizzi Coelho-Filho |
author_facet |
Thiago Ferreira de Souza Thiago Quinaglia Silva Lígia Antunes-Correa Zsofia D. Drobni Felipe Osório Costa Sergio San Juan Dertkigil Wilson Nadruz Fabrício Brenelli Andrei C. Sposito José Roberto Matos-Souza Otávio Rizzi Coelho Tomas G. Neilan Michael Jerosch-Herold Otávio Rizzi Coelho-Filho |
author_sort |
Thiago Ferreira de Souza |
title |
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
title_short |
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
title_full |
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
title_fullStr |
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
title_full_unstemmed |
Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
title_sort |
cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/86f331c601744a65ba8265c0d625b14e |
work_keys_str_mv |
AT thiagoferreiradesouza cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT thiagoquinagliasilva cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT ligiaantunescorrea cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT zsofiaddrobni cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT felipeosoriocosta cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT sergiosanjuandertkigil cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT wilsonnadruz cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT fabriciobrenelli cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT andreicsposito cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT joserobertomatossouza cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT otaviorizzicoelho cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT tomasgneilan cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT michaeljeroschherold cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy AT otaviorizzicoelhofilho cardiacmagneticresonanceassessmentofrightventricularremodelingafteranthracyclinetherapy |
_version_ |
1718383766272999424 |